Pietro Panei

Summary

Affiliation: Istituto Superiore di Sanit
Country: Italy

Publications

  1. pmc An inventory of European data sources for the long-term safety evaluation of methylphenidate
    Macey L Murray
    Centre for Paediatric Pharmacy Research, University College London School of Pharmacy, London, UK
    Eur Child Adolesc Psychiatry 22:605-18. 2013
  2. pmc Framework conditions facilitating paediatric clinical research
    Anne Laure Knellwolf
    Dept, of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanita, Rome, Italy
    Ital J Pediatr 37:12. 2011
  3. ncbi request reprint [ADHD register: post-marketing evaluation of the benefit-risk profile of drugs and promotion of the appropriateness]
    Pietro Panei
    Dipartimento del Farmaco, Istituto Superiore di Sanita, Roma
    Recenti Prog Med 104:254-61. 2013

Collaborators

  • Macey L Murray
  • Anne Laure Knellwolf
  • Jan K Buitelaar
  • Ian C K Wong
  • Tobias Banaschewski
  • Ralf W Dittmann
  • Suzanne McCarthy
  • David Coghill
  • Suppachai Insuk
  • Edmund J Sonuga-Barke
  • Antje C Neubert
  • Eric Rosenthal
  • Kerstin Konrad
  • Stéphane Bauzon
  • Deborah Alfarez
  • Ornella Della Casa Alberighi
  • Irja Lutsar
  • Ernö Bácsy

Detail Information

Publications3

  1. pmc An inventory of European data sources for the long-term safety evaluation of methylphenidate
    Macey L Murray
    Centre for Paediatric Pharmacy Research, University College London School of Pharmacy, London, UK
    Eur Child Adolesc Psychiatry 22:605-18. 2013
    ..Many European healthcare databases can be used for multinational long-term safety studies of MPH. Methodological research is underway to investigate the feasibility of their pooling and analysis...
  2. pmc Framework conditions facilitating paediatric clinical research
    Anne Laure Knellwolf
    Dept, of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanita, Rome, Italy
    Ital J Pediatr 37:12. 2011
    ..This article addresses ethical and legal issues arising from the regulation and makes recommendations for the framework conditions facilitating the development of clinical research with children...
  3. ncbi request reprint [ADHD register: post-marketing evaluation of the benefit-risk profile of drugs and promotion of the appropriateness]
    Pietro Panei
    Dipartimento del Farmaco, Istituto Superiore di Sanita, Roma
    Recenti Prog Med 104:254-61. 2013
    ..The Register was aimed at assessing the benefit-risk profile of the treatment of attention deficit hyperactivity disorder (ADHD) with atomoxetine and methylphenidate...